Form 4: Aspira Women's Health Interim CEO Sandra Milligan Acquires 20,000 Shares Through RSU Vesting
SEC Form 4
Aspira Women's Health Interim CEO Sandra Milligan acquired 20,000 shares of common stock through the vesting of restricted stock units on December 31, 2024.
Summary
- Sandra Milligan, Interim CEO and President of Aspira Women's Health Inc., acquired 20,000 shares of common stock.
- The acquisition occurred on December 31, 2024, through the vesting of previously granted restricted stock units (RSUs).
- These RSUs were initially granted on October 28, 2024, and vested on December 31, 2024.
- The conversion of the RSUs into common stock is reported in Table I of the SEC Form 4.
- Each RSU is equivalent to one share of Aspira Women's Health Inc. stock.
Sentiment
Score: 7
Explanation: The document reflects a routine transaction related to executive compensation. The acquisition of shares by the CEO is a positive sign, but it's not a major event that would significantly impact the company's outlook.
Positives
- The vesting of RSUs indicates that the CEO is meeting performance or time-based criteria set by the company.
- The acquisition of shares by the CEO can be seen as a positive sign of confidence in the company's future.
Industry Context
This is a routine transaction related to executive compensation and is common in publicly traded companies. It reflects the vesting of previously granted equity awards.
Comparison to Industry Standards
- The use of restricted stock units (RSUs) as part of executive compensation is a common practice among publicly traded companies, including those in the healthcare and biotechnology sectors.
- Vesting schedules for RSUs typically range from one to four years, with vesting often tied to continued employment or performance milestones.
- The vesting of 20,000 RSUs for the Interim CEO is within the typical range for executive compensation packages in similar companies.
- Companies like Myriad Genetics and Exact Sciences also use RSUs as part of their executive compensation packages.
Stakeholder Impact
- The acquisition of shares by the CEO may be viewed positively by shareholders, indicating confidence in the company's future.
Key Dates
| Date | Description |
|---|---|
| 10/28/2024 | Date the reporting person was granted 20,000 RSUs. |
| 12/31/2024 | Date the 20,000 RSUs vested and converted into common stock. |
| 01/08/2025 | Date the SEC Form 4 was signed. |
Keywords
Aspira Women's Health, Sandra Milligan, Restricted Stock Units, RSU, Stock Acquisition, SEC Form 4, Insider Trading, Executive Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.